Qing Chen

Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma

Deborah J. Kuhn, Qing Chen, Peter M. Voorhees et al. · Blood · 2007 · 768 citations · Full text

Medicine, Oncology, Pharmacology +13

Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors

Deborah J. Kuhn, Sally A. Hunsucker, Qing Chen et al. · Blood · 2008 · 206 citations · Full text

Medicine, Immunology, Oncology +15

Inhibition of Interleukin-6 Signaling with CNTO 328 Enhances the Activity of Bortezomib in Preclinical Models of Multiple Myeloma

Peter M. Voorhees, Qing Chen, Deborah J. Kuhn et al. · Clinical Cancer Research · 2007 · 115 citations · Full text

Medicine, Oncology, Pharmacology +15

International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings

Jill R. Storry, Frederik Banch Clausen, Lilian Castilho et al. · Vox Sanguinis · 2018 · 99 citations · Full text

Medicine, Hematology, Immunology +6

Brain Iron, Transferrin and Ferritin Concentrations Are Altered in Developing Iron-Deficient Rats

Qing Chen, James R. Connor, John L. Beard · Journal of Nutrition · 1995 · 88 citations · Full text

Medicine, Neurobiology, Neuroscience +16